Tumor Necrosis Factor Blocker [EPC] - N0000175610

Name: Table of NDC products with tumor necrosis factor blocker
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000175610
Pharmacologic Name	Tumor Necrosis Factor Blocker
Pharmacologic Uses	tumor necrosis factor (TNF) blocker
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Tumor Necrosis Factor Blocker

The table contains 62 products whose active ingredient are classified under the same pharmacologic class Tumor Necrosis Factor Blocker [EPC].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0069-0809	Inflectra	Non-Proprietary Name: Infliximab-dyyb	Injection, Powder, Lyophilized, For Solution	Intravenous	Pfizer Laboratories Div Pfizer Inc	ACTIVE
50090-6704	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
50090-6705	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
50090-6706	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
50090-6707	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
50474-710	Cimzia	Non-Proprietary Name: Certolizumab Pegol	Injection, Solution	Subcutaneous	Ucb, Inc.	ACTIVE
50474-750	Cimzia	Non-Proprietary Name: Certolizumab Pegol	Injection, Solution	Subcutaneous	Ucb, Inc.	ACTIVE
55513-399	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-400	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-410	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-411	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-413	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-479	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-480	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-481	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-482	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-670	Avsola	Non-Proprietary Name: Infliximab-axxq	Injection, Powder, Lyophilized, For Solution	Intravenous	Amgen, Inc	ACTIVE
57894-030	Remicade	Non-Proprietary Name: Infliximab	Injection, Powder, Lyophilized, For Solution	Intravenous	Janssen Biotech, Inc.	ACTIVE
57894-070	Simponi	Non-Proprietary Name: Golimumab	Injection, Solution	Subcutaneous	Janssen Biotech, Inc.	ACTIVE
57894-071	Simponi	Non-Proprietary Name: Golimumab	Injection, Solution	Subcutaneous	Janssen Biotech, Inc.	ACTIVE
57894-160	Infliximab	Non-Proprietary Name: Infliximab	Injection, Powder, Lyophilized, For Solution	Intravenous	Janssen Biotech, Inc.	ACTIVE
57894-350	Simponi Aria	Non-Proprietary Name: Golimumab	Solution	Intravenous	Janssen Biotech, Inc.	ACTIVE
58406-010	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-021	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-032	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-044	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-055	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
61314-325	Adalimumab	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-327	Adalimumab	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-332	Adalimumab	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-391	Adalimumab	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-454	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-473	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-476	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-509	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
70114-210	Yusimry	Non-Proprietary Name: Adalimumab-aqvh	Injection, Solution	Subcutaneous	Coherus Biosciences Inc	ACTIVE
70114-220	Yusimry	Non-Proprietary Name: Adalimumab-aqvh	Injection, Solution	Subcutaneous	Coherus Biosciences Inc	ACTIVE
71288-815	Yusimry	Non-Proprietary Name: Adalimumab-aqvh	Injection, Solution	Subcutaneous	Meitheal Pharmaceuticals Inc.	ACTIVE
71288-816	Yusimry	Non-Proprietary Name: Adalimumab-aqvh	Injection, Solution	Subcutaneous	Meitheal Pharmaceuticals Inc.	ACTIVE
72511-399	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
72511-400	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
72511-479	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
72511-481	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
72511-482	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
72606-047	Zymfentra	Non-Proprietary Name: Infliximab-dyyb	Injection	Subcutaneous	Celltrion Usa Inc.	ACTIVE
78206-162	Renflexis	Non-Proprietary Name: Infliximab	Injection, Powder, Lyophilized, For Solution	Intravenous	Organon Llc	ACTIVE
78206-183	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-184	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-185	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-186	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-187	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
83457-100	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-101	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-102	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-103	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-107	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-108	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-113	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
84612-399	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Optum Health Solutions (ireland) Limited	ACTIVE
84612-479	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Optum Health Solutions (ireland) Limited	ACTIVE
84612-481	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Optum Health Solutions (ireland) Limited	ACTIVE
84612-482	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Optum Health Solutions (ireland) Limited	ACTIVE